Lucite tombstone marking a follow-on offering by RXi Pharmaceuticals, a biotech firm based in Marlborough, Massachusetts.
These custom designs highlight deal toys within the healthcare space, but also include vial embedments for drug launches, and commemoratives for FDA approval milestones, therapeutic studies, in-human testing, and other industry landmarks.
Lucite tombstone marking a follow-on offering by RXi Pharmaceuticals, a biotech firm based in Marlborough, Massachusetts.
Lucite tombstone marking the sale of a stake in Wellington-based health supplements firm, The Better Health Company. The acquisition was made by a fund controlled China Diamonds Holdings, located in Singapore.
(6ADL722)Syringe-themed Lucite tombstone marking the acquisition of five pain management and anesthesia drugs from Belgian pharmaceutical firm Janssen.
(7LAC028)Custom Lucite recognizing the leadership of CleanSlate Addiction Treatment Centers.
(6ALC26)Hospital-themed Lucite tombstone marking the acquisition of a stake in Dermatologikum Hamburg, a private medical facility specializing in skin disorders. The stake was purchased by German investment firm ECM.
(7LJW004)Hospital-themed tombstone marking the acquisition of Düsseldorf, Germany-based AHG, an operator of rehabilitation clinics. The acquirer was MEDIAN, a health care provider and portfolio company of private equity firm Waterland.
(6LJWE14)Lucite tombstone commemorating a transaction involving the Amma Group, a Spanish operator of residential and day care facilities for the elderly.
(7LAC056)Deal toys in the healthcare and pharmaceutical space reflect a broad range of financial transactions. These deals involve an array of industry players, including drug companies, hospital chains, medtech firms, manufacturers of medical devices, developers of diagnostic equipment, senior living facilities, pharmacies, and testing laboratories, as well as healthcare-focused funds and venture capital firms.
The transactions themselves include mergers and acquisitions, initial public offerings, bond issues, financings, private placements, and early-stage funding rounds.
But also represented here are transactions more unique to the sector, such as drug licensing, royalty, and commercialization agreements.
The custom designs in these galleries also celebrate non-financial industry achievements and milestones. You will see here, for instance, commemoratives involving submissions and approvals from the Food & Drug Administration (FDA) and European Medicines Agency (EMA), therapeutic studies, joint ventures, successful preclinical and in-human testing stages, and product launches.
These milestones can be commemorated with designs incorporating items unique to the specific event, achievement, or innovation being recognized. These design options include, for example, Lucite embedments of actual drug vials and medical devices.
You’ll also find here commemoratives for a variety of other sector-related events. These include custom awards and gifts honoring speakers and attendees at national and international health summits and medical conferences.
"*" indicates required fields
